GDTC: Nilai perusahaan marang bathi resik w2.cytomed.sg
CytoMed Therapeutics (GDTC) is accelerating preclinical trials through robotic compound screening, which is critical for NK-cell survival and scaling production in Singapore. Market price action on GURU.Markets for the separate_pe metric currently stands at -3.70. The Singapore-based cell therapy developer is not yet profitable, relying instead on the success of current tests and future regulatory approvals to bring its drugs to market.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_GDTC_-_CytoMed-Therapeutics_-_PE-Multiple "GDTC: Koefisien rega marang bathi CytoMed Therapeutics 21.02.2024 - 12.11.2026 | 👁️GURU.Markets👁️")
Rincian metrik komprehensif lan analitis CytoMed Therapeutics Ltd (GDTC)
- rega saham lan prakiraan rega para ahli:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi CytoMed Therapeutics|GDTC - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal CytoMed|GDTC - Gunggung utang perusahaan|Utang marang nilai buku CytoMed Therapeutics Limited|GDTC - Kewajiban jangka dawa perusahaan|Utang jangka cendhak CytoMed Therapeutics|Rasio likuiditas perantara w2.cytomed.sg
- indikator profitabilitas perusahaan lan kelipatan valuasi:
GDTC - Bathi resik perusahaan|Bathi resik sing dikarepake CytoMed Therapeutics|GDTC - Rasio rega marang bathi|Prakiraan rega marang bathi CytoMed|GDTC - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CytoMed Therapeutics Limited|GDTC - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan CytoMed Therapeutics|GDTC - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan w2.cytomed.sg|GDTC - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep CytoMed Therapeutics
Ringkesan analisis perusahaan:GDTC w2.cytomed.sg
Market expectations for CytoMed Therapeutics (GDTC) often outpace current earnings due to the high cost of developing T-cell therapies and stringent FDA oversight. By analyzing the company's annual P/E ratio, an investor assesses the relationship between market capitalization and net income, which helps determine the premium paid for exclusive patents and the business's lobbying potential in Asia.
Perusahaan pesaing
ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (Ascentage)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis (PSNL) - Rasio rega marang bathi|Erasca Inc - Nilai perusahaan marang bathi resik|DCTH (Delcath) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Corp YMAB|Pangali P/E AURA|Koefisien rega marang bathi candeltx.com CADL|Accuray - Koefisien rega marang bathi|SELLAS Life Sciences Group, Inc. (SLS) - Kapitalisasi marang bathi|ACTU: Koefisien rega marang bathi|Citius Oncology Inc - Rasio rega pasar marang bathi resik|tuhurabio.com (HURA) - Rasio rega marang bathi|Kapitalisasi marang bathi protaratx.com (TARA)|Rasio rega marang bathi Fate Therapeutics|Koefisien rega marang bathi Aadi Bio (WHWK)|Pangali P/E TCRX|CSBR - Kapitalisasi marang bathi|Pangali P/E XBIT (XBiotech)|CVM: Pangali rega marang bathi|OSTX: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik RADX (radiopharmtheranostics.com)|ARTV (artivabio.com) - Koefisien rega marang bathi|ANL: Rasio rega pasar marang bathi resik|VERU (Veru Inc.) - Pangali P/E|TPST: Nilai perusahaan marang bathi resik|Pangali P/E XLO|RENB - Kapitalisasi marang bathi|Rasio rega marang bathi Mural Oncology MURA|Nilai perusahaan marang bathi resik KAPA|OnKure - Pangali P/E|CRIS - Pangali P/E|apollomicsinc.com (APLM) - Rasio rega marang bathi|Kapitalisasi marang bathi resik THAR (Tharimmune Inc)|ADVB (Advanced Biomed Inc.) - Pangali P/E|Kapitalisasi marang bathi Genprex Inc GNPX|Koefisien rega marang bathi CLDI (Calidi Biotherapeutics)|Pangali P/E sunshinebiopharma.com (SBFM)|Xenetic Biosciences, Inc. - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik SLRX (Salarius Pharmaceuticals Inc)|Purple Biotech Corp - Pangali P/E|Periode bali modal bisnis American Oncology Network AONC|BGNE: Pangali P/E|Koefisien rega marang bathi checkpointtx.com|Rasio rega marang bathi Elevation Oncology|iCAD Corp (ICAD) - Periode bali modal bisnis|Pangali P/E IKNA|Notable Labs Corp (NTBL) - Rasio kapitalisasi marang bathi resik|Pangali P/E VIRX (Viracta Therapeutics, Inc.)|MOR: Pangali rega marang bathi|NAYA: Koefisien rega marang bathi|Ascentage Pharma Group International - Rasio rega pasar marang bathi resik
